AWA
FLGT icon

Authentikos Wealth Advisory’s Fulgent Genetics FLGT Stock Holding History

Authentikos Wealth Advisory’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-67
Closed -$1.79K – 228
2023
Q3 		$1.79K Buy
+67
New +$2.29K ﹤0.01% 447

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Authentikos Wealth Advisory's FLGT Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 67 shares — an estimated $1.79K sold.

Authentikos Wealth Advisory first reported a position in FLGT in Q3 2023 and held it in 1 quarter. The position peaked at $1.79K in Q3 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 67 Fulgent Genetics shares in Q4 2023, an estimated $1.79K.
  • Authentikos Wealth Advisory first reported a position in Fulgent Genetics in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's Fulgent Genetics position peaked at $1.79K in Q3 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.